Per Harald Borgen

Chief Executive Officer at

Scrimba AS

Consumer Services

Distribution Services

Technology Services

Profile

Per Harald Borgen was the founder of Propell, holding the title of Co CEO from 2012 to 2015.
Mr. Borgen is the founder of Scrimba AS, holding the title of Chief Executive Officer since 2016.
Mr. Borgen is a Venture Partner at Pioneer Fund.
Mr. Borgen has an undergraduate degree from the University of Oslo.

Per Harald Borgen active positions

Companies	Position	Start
Scrimba AS Scrimba AS Packaged SoftwareTechnology Services Develops video format software for communicating code	Chief Executive Officer	01/10/2016
Pioneer Fund/NY/ Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund invests in companies located across the globe. The firm targets companies operating in the fields of biotechnology, healthcare and life sciences sectors. It provides financing for seed and early stage capital requirements.	Private Equity Investor	-

All active positions of Per Harald Borgen

Former positions of Per Harald Borgen

Companies	Position	End
Propell Propell Wholesale DistributorsDistribution Services Manufactures industrial equipments	Chief Executive Officer	01/01/2015

See the detail of Per Harald Borgen's experience

Training of Per Harald Borgen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Per Harald Borgen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
University of Oslo University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Propell Propell Wholesale DistributorsDistribution Services Manufactures industrial equipments	Distribution Services
Scrimba AS Scrimba AS Packaged SoftwareTechnology Services Develops video format software for communicating code	Technology Services
Pioneer Fund/NY/ Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund invests in companies located across the globe. The firm targets companies operating in the fields of biotechnology, healthcare and life sciences sectors. It provides financing for seed and early stage capital requirements.	Finance